RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253030

FDA DEVICE FACTS

Capnostream™35 Portable Respiratory Monitor (PM35MN)

Covidien, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 1, 2026PRODUCT CODECCK

Indications for use

The Capnostream 35 monitor is a portable capnograph and pulse oximetry monitor indicated for non-invasive monitoring of carbon dioxide concentration of the expired and inspired breath (EtCO2), respiration rate (RR), arterial oxygen saturation (SpO2), and pulse rate (PR) in patient populations, including adults, pediatrics, and neonates. The Capnostream 35 monitor is indicated for use by professionally trained health care providers. The Capnostream 35 monitor is intended for use in hospitals, hospital-type facilities, intra-hospital transport, mobile emergency medical applications including both ground and air transport, unless otherwise noted. Transport environments include intra-hospital transport and both ground and air emergency transport: road ambulances and rotary-wing aircraft. The Capnostream 35 monitor with Microstream capnography and accessories is indicated for continuous non-invasive monitoring of capnography-derived respiratory rate, integrated pulmonary index (IPI), apnea per hour (A/hr), and oxygen desaturation index (ODI) values. IPI is intended for pediatric and adult patients only. A/hr and ODI are intended for adult patients only. The Capnostream 35 monitor with Nellcor pulse oximeter and accessories are indicated for providing spot-check and/or continuous non-invasive monitoring of arterial oxygen saturation (SpO2), pulse rate (PR), pleth-derived respiratory rate, Saturation Pattern Detection (SPD), heart rate variability (HRV), and perfusion index (PI). It is intended for use with patients who are well- or poorly perfused, during both no-motion and motion conditions. The device is intended to maintain accuracy in monitoring conditions in which patient and/or pulse oximetry sensor characteristics may affect measurements, by leveraging patient-specific and sensor-specific information to aid in arterial oxygen saturation calculation. The Saturation Pattern Detection Alert (SPD) parameter is intended to detect patterns of desaturation indicative of repetitive reductions in airflow through the upper airway and into the lungs for continuous monitoring of adults in hospital, hospital-type facilities, and during intra-hospital transport only. The Respiration Rate (RR) parameter, when used in conjunction with a Nellcor Respiration Rate sensor, is intended to be used for spot-check or continuous monitoring of respiration rate in adults in hospital, hospital-type facilities, and during and intra-hospital transport only. The Heart Rate Variability (HRV) is intended for continuous monitoring of the variability of a patient's pulse rate. The Heart Rate Variability is intended to analyze the pulse rate provided by the oximeter and provide visualization of trends in the pulse rate and HRV values. The perfusion index is intended for spot-check or continuous monitoring of peripheral perfusion at the pulse oximetry sensor site and provides the ratio of the pulsatile blood to non-pulsatile or static blood in peripheral tissue. Prescription Use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026